(MD+DI) – Back in April, MD+DI published an article offering five reasons that this would be Zimmer Biomet’s comeback year, and the Warsaw, IN-based company did not let us down. In fact, Zimmer Biomet accomplished even more in 2019 than we could have predicted at that time. […]
Zimmer Biomet, a global leader in musculoskeletal healthcare, today announced FDA 510(k) clearance for the Persona® Revision Knee System for revision knee replacement procedures. […]
(MD+DI) – An industry analyst expects Zimmer Biomet’s Rosa Knee robotic system to represent a formidable competitor to Stryker’s Mako Knee after the Rosa Knee’s full launch later this year. However, both Mako and Rosa have their strengths and weaknesses, and neither is clearly superior, the analyst said. […]
(MassDevice) – Stryker’s success with its Mako robot-assisted surgery platform has other orthopedic device companies hastening to enter the space. The big question is whether long-term outcomes will justify the expensive technology. […]
(MD+DI) – Zimmer Biomet’s revenue growth is expected to accelerate during 2019 as the company shifts back to offense after addressing supply issues that have plagued the orthopedic device maker since 2016. […]
(MD+DI) – After spending 2018 dealing with quality control remediation and supply chain issues, Zimmer Biomet expects to return to market growth by 2020. […]
Copyright © 2020 | MH Magazine WordPress Theme by MH Themes